News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Anatara Lifesciences.
RELATED STOCKHEAD STORIES
News
10 at 10: These ASX stocks have made it to the next stage of their journey this morning
Health & Biotech
Cannabis, medtech, telehealth – could any of these health microcaps be the next multi-bagger?
News
Trading Places: Alex Waislitz’s Thorney Opportunities chipped in to these ASX stocks
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Check up: A good fortnight to be a small cap health investor
Health & Biotech
Factor Therapeutics may finally have found its future — in veterinary imaging
Health & Biotech
ASX investors super happy that FDA may approve first new contraceptive pill in 11 years
Health & Biotech
When your guts have gone nuts, who do you call? These ASX stocks are fighting gastrointestinal disease
Stockhead TV
VIDEO: 90 Seconds With… Steven Lydeamore, Anatara Lifesciences
Health & Biotech
Check up: Cashing in on deals done long ago
News
Trading Places: Here are this week’s substantial holder movements
Health & Biotech
Health: Alterity gets orphan status for its MSA drug
Health & Biotech
Health: Gut treatment progress gives Anatara a 24pc boost
Health & Biotech
Our pets are living longer, happier lives and it’s a $US125bn market; here are the small cap contenders
Health & Biotech
Here’s what policymakers must do keep ASX life science companies from going overseas
Health & Biotech
